<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recent technological advances allow analysis of genomic changes in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in unprecedented detail </plain></SENT>
<SENT sid="1" pm="."><plain>The next challenge is to prioritize the multitude of genetic aberrations found and identify therapeutic opportunities </plain></SENT>
<SENT sid="2" pm="."><plain>We recently completed a study that illustrates the use of unbiased genetic screens and murine <z:e sem="disease" ids="C1516211" disease_type="Experimental Model of Disease" abbrv="">cancer models</z:e> to find therapeutic targets among complex genomic data </plain></SENT>
<SENT sid="3" pm="."><plain>We genetically dissected the common deletion of chromosome 6q and identified the ephrin receptor A7 (EPHA7) as a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor in <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Notably, EPHA7 encodes a soluble splice variant that acts as an extrinsic <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor </plain></SENT>
<SENT sid="5" pm="."><plain>Accordingly, we developed an antibody-based strategy to specifically deliver EPHA7 back to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> that have lost this gene </plain></SENT>
<SENT sid="6" pm="."><plain>Recent sequencing studies have implicated EPHA7 in <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> and other <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, suggesting a broader therapeutic potential for antibody-mediated delivery of this <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> therapy </plain></SENT>
<SENT sid="7" pm="."><plain>Together, our comprehensive approach provides new insights into <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> biology and may directly lead to the development of new <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> therapies </plain></SENT>
</text></document>